Top 20 Pharma Ranks: As Some Move Up, Others Fall Down
Executive Summary
Sanofi and Gilead moved down in the rankings of Scrip's top 100 pharmaceutical companies, based on 2017 pharma sales, while Johnson & Johnson, GSK and AbbVie moved up. Shire joined the top 20 just as it is about to be consumed by Takeda.
You may also be interested in...
Merck's Keytruda Doubled PFS In Some Colorectal Cancer Patients In ASCO Late-Breaker
Pembrolizumab should be considered the new standard of care as first-line therapy in patients with microsatellite instability high (MSI-H) metastatic colorectal cancer, KEYNOTE-177 investigator André said.
‘Business Unusual’: COVID-19 Brought Commercial Changes To Pharma And It May Stick
The pharmaceutical selling model will be modified even after the immediate COVID-19 pandemic crisis abates, the consulting firm ZS Associates predicts, citing new research.
A Considerable Setback For Cancer Trials Because Of COVID-19, IQVIA/CRI Survey Finds
Patient enrollment in clinical trials for cancer drugs was "severely" affected by the COVID-19 pandemic, according to a report published in Nature Reviews Drug Discovery.
Need a specific report? 1000+ reports available
Buy Reports